A Noninterventional Study of Vimpat (Lacosamide) as Adjunctive Antiepileptic Drug Therapy in Patients With Brain Tumor-related Epilepsy
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Acronyms VIBES
- Sponsors UCB
- 17 Jul 2017 Planned End Date changed from 1 Aug 2017 to 1 Jan 2018.
- 17 Jul 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jan 2018.
- 17 Jul 2017 Status changed from recruiting to active, no longer recruiting.